This inventor holds 1 USPTO granted patent. Top assignee: Vigilant Biosciences, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Matthew H J Kim
Introduction
Matthew H J Kim is an accomplished inventor based in Parkland, FL (US). He has made significant strides in the field of medical technology, particularly in the early detection of diseases. His innovative approach has the potential to impact cancer diagnosis and treatment.
Latest Patents
Matthew holds a patent for a "Device for early detection of disease states." This device is designed to test biological samples and includes a housing, two or more test pads, and a sample pad. The sample pad is in fluid communication with an opening in the housing for receiving the biological sample. Each test pad is configured to test the biological sample, with at least one window allowing visibility of the test pads from outside the housing. Notably, one test pad detects a threshold amount of CD44, while another detects total protein in the biological sample. The results from these tests are crucial for the early detection of cancers.
Career Highlights
Matthew is currently associated with Vigilant Biosciences, Inc., where he continues to develop innovative solutions in the healthcare sector. His work focuses on enhancing diagnostic tools that can lead to timely interventions in disease management.
Collaborations
Matthew has collaborated with notable professionals in his field, including Robert C Bohannon and Steven C Bohannon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Matthew H J Kim's contributions to medical technology, particularly in early disease detection, highlight his role as a significant inventor in the healthcare industry. His innovative device represents a promising advancement in cancer diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile